Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options. Leveraging extensive domain expertise, we have identified and acquired or in-licensed  development-stage proprietary compounds with what we believe are innovative mechanisms of action. Our executive management team and Board of Directors include globally recognized specialists in central nervous system diseases and clinical development.